MTC Survivorship: Monitoring and Managing Anxiety

For many patients with Medullary Thyroid Carcinoma (MTC), the journey does not end with surgery. Because MTC often grows slowly, survivorship is frequently a process of long-term “active surveillance” or chronic management ^[1]. Understanding how your doctors monitor you—and why they might choose not to act on every small change—is key to your peace of mind.

Defining Your Status

After your recovery from surgery, your doctor will categorize your status into one of two main groups ^[1]:

• Biochemical Cure: Your serum calcitonin and CEA levels are undetectable. This is the goal of surgery, though it still requires periodic monitoring to ensure the cancer has not returned ^[2].
• Persistent Biochemical Disease: Your calcitonin is detectable (above zero), but your scans (CT, MRI, ultrasound) show no visible tumors. Many MTC patients live for decades in this state without the cancer ever impacting their quality of life ^[1].

The Power of “Doubling Time”

In MTC, the velocity of your markers (how fast they rise) is far more important than the absolute number at any single point in time. Your doctor will track your doubling time—the amount of time it takes for your calcitonin or CEA level to double ^[3].

• Indolent (Slow): A doubling time of greater than 2 years is generally a very good sign, indicating the cancer is growing extremely slowly.
• Intermediate: A doubling time between 6 months and 2 years requires closer monitoring.
• Aggressive (Fast): A doubling time of less than 6 months suggests the cancer is active and may require a change in treatment or more frequent imaging.

When Do We Use Scans?

It can be tempting to want a scan every time your calcitonin goes up slightly. However, standard scans (like CT or MRI) are often unable to “see” MTC until the calcitonin reaches a certain level.

Current guidelines generally recommend initiating structural imaging when your calcitonin level exceeds 150 pg/mL or when your doubling time is rapidly shortening ^[4]. Scanning below this threshold often results in “false negatives” (not seeing anything), which can cause unnecessary stress without providing useful information.

Navigating “Scanxiety”

The psychological toll of living with a chronic biomarker like calcitonin is real. “Scanxiety”—the distress felt before a scan or while waiting for results—is a common experience for MTC survivors.

To help manage this chronic stress:

• Minimize the Wait: Ask your clinic to schedule a follow-up appointment or call within 24–48 hours of your tests to reduce the “black hole” of waiting.
• Focus on Trends: Remind yourself that a single high lab result is just one data point. Doctors look for a pattern over at least three consecutive measurements before making major treatment changes. Additionally, keep in mind that normal illnesses, such as a severe cold or a flare of another condition, can sometimes temporarily cause lymph nodes to swell, which is not necessarily a sign of cancer returning.
• Control the Narrative: Some patients find comfort in keeping their own spreadsheet of labs to calculate their own doubling times, while others prefer to let their doctor handle the data. Choose the approach that feels most empowering to you.